Asahi Kasei Pharma Strengthens Preclinical Pipeline Through Exclusive Global License Agreement with Alchemedicine for Novel Lead Compounds [Yahoo! Finance]
ASAHI KAISEI CRP UNSP/ADR (AHKSY)
NASDAQ:AMEX Investor Relations:
asahi-kasei.co.jp/asahi/en/ir
Company Research
Source: Yahoo! Finance
Asahi Kasei's Tokyo Headquarters TOKYO, February 25, 2026 BUSINESS WIRE Asahi Kasei Pharma announced that it has strengthened its drug discovery pipeline through an exclusive global license agreement regarding novel lead compounds for a single target with Alchemedicine, a company specializing in the discovery of small molecule drugs. The license agreement was executed on February 3, 2026, and follows the companies' recent announcement on advancing AK1960 to a Phase I study Under the agreement, Asahi Kasei Pharma obtained exclusive worldwide rights to research, develop, manufacture, and commercialize the compounds, which are currently at the preclinical stage. The compounds were identified using Alchemedicine's drug discovery platform, HiSAP™ and are expected to have therapeutic potential for multiple autoimmune diseases. The specific target indications will be determined by Asahi Kasei Pharma as development progresses. This agreement represents the second license agreement betw
Show less
Read more
Impact Snapshot
Event Time:
AHKSY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AHKSY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AHKSY alerts
High impacting ASAHI KAISEI CRP UNSP/ADR news events
Weekly update
A roundup of the hottest topics
AHKSY
News
- Asahi Kasei to acquire Aicuris Anti-infective Cures for $920.7m [Yahoo! Finance]Yahoo! Finance
- Assessing Asahi Kasei (TSE:3407) Valuation After Its Strong Recent Share Price Momentum [Yahoo! Finance]Yahoo! Finance
- Asahi Kasei Strengthens Global Pharmaceutical Platform with the Acquisition of Aicuris [Yahoo! Finance]Yahoo! Finance
- Asahi Kasei Strengthens Global Pharmaceutical Platform with the Acquisition of AicurisBusiness Wire
- Asahi Kasei to Acquire Aicuris to Accelerate Growth in Severe Infectious Diseases [Yahoo! Finance]Yahoo! Finance